Patent Assignment
Reel/Frame 067808/0425
Release of Security Interest
Recorded: 2024-06-22
Pages: 8
Assignor
INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Executed: 2024-06-21
Assignee
EPIC SCIENCES, INC.
9381 JUDICIAL DRIVE, SUTIE 200, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(19)
Circulating Tumor Cell Diagnostics for Biomarkers Predictive of Resistance to Androgen Receptor (Ar) Targeted Therapies
Application:
15/478,002 →
Publication:
US 2018/0052167
Compositions and Methods for Prostate Cancer Analysis
Application:
16/721,108 →
Publication:
US 2020/0200752
Circulating Tumor Cell Diagnostics for Prostate Cancer Biomarkers
Application:
16/691,461 →
Publication:
US 2020/0333345
Methods for Analyzing Rare Circulating Cells
Methods of Using Non-Rare Cells to Detect Rare Cells
Application:
16/819,684 →
Publication:
US 2021/0033612
Circulating Tumor Cell Diagnostics for Detection of Neuroendocrine Prostate Cancer (Nepc)
Application:
14/605,809 →
Publication:
US 2016/0040245
Circulating Tumor Cell Diagnostics for Identification of Resistance to Androgen Receptor Targeted Therapies
Application:
15/513,915 →
Publication:
US 2017/0285035
Intra-Patient Genomic Heterogeneity of Single Circulating Tumor Cells (Ctcs) Associated to Phenotypic Ctc Heterogeneity in Metastatic Castrate Resistant Prostate Cancer (Mcrpc)
Application:
15/577,307 →
Publication:
US 2018/0155794
ANDROGEN RECEPTOR VARIANT 7 AS A BIOMARKER FOR TREATMENT SELECTION IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (mCRPC)
Application:
15/762,076 →
Publication:
US 2019/0285636
Single Cell Genomic Profiling of Circulating Tumor Cells (Ctcs) in Metastatic Disease to Characterize Disease Heterogeneity
Application:
16/068,348 →
Publication:
US 2019/0025312
Methods for Detecting 5T4-Positive Circulating Tumor Cells and Methods of Diagnosis of 5T4-Positive Cancer in a Mammalian Subject
Method of Using Non-Rare Cells to Detect Rare Cells
Circulating Tumor Cell Diagnostics for Prostate Cancer Biomarkers
Methods for Analyzing Rare Circulating Cells
Enhanced Characterization of Breast Cancer
Application:
18/076,945 →
Publication:
US 2023/0175073
Detection of Prostate Specific Membrane Antigen (Psma) Expression on Circulating Tumor Cells (Ctc)
Application:
14/605,913 →
Publication:
US 2016/0011198
Detection of Prostate Specific Membrane Antigen (Psma) Expression on Circulating Tumor Cells (Ctc)
Application:
18/308,579 →
Publication:
US 2024/0103003
Circulating Tumor Cell Diagnostics for Biomarkers Predictive of Resistance to Androgen Receptor (Ar) Targeted Therapies
Application:
14/609,356 →
Publication:
US 2015/0212089
Circulating Tumor Cell Diagnostics for Biomarkers Predictive of Resistance to Androgen Receptor (Ar) Targeted Therapies
Application:
17/323,976 →
Publication:
US 2022/0091124
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 23, 2015
From: DITTAMORE, RYAN
To: EPIC SCIENCES, INC.
Reel/Frame 035234/0620 →
Assignment of Assignor's Interest
Mar 23, 2015
From: DITTAMORE, RYAN
To: EPIC SCIENCES, INC.
Reel/Frame 035235/0031 →
Assignment of Assignor's Interest
Mar 23, 2015
From: DITTAMORE, RYAN
To: EPIC SCIENCES, INC.
Reel/Frame 035235/0100 →
Assignment of Assignor's Interest
Mar 23, 2015
From: DITTAMORE, RYAN
To: EPIC SCIENCES, INC.
Reel/Frame 035234/0509 →
Assignment of Assignor's Interest
Jul 19, 2019
From: DITTAMORE, RYAN
To: EPIC SCIENCES, INC.
Reel/Frame 049809/0359 →
Assignment of Assignor's Interest
Jul 19, 2019
From: MARRINUCCI, DENA
To: EPIC SCIENCES, INC.
Reel/Frame 049809/0353 →
Assignment of Assignor's Interest
Jul 19, 2019
From: DITTAMORE, RYAN
To: EPIC SCIENCES, INC.
Reel/Frame 049809/0333 →
Assignment of Assignor's Interest
Jul 19, 2019
From: DITTAMORE, RYAN; LANDERS, MARK
To: EPIC SCIENCES, INC.
Reel/Frame 049809/0342 →
Assignment of Assignor's Interest
Jul 19, 2019
From: DITTAMORE, RYAN; MARRINUCCI, DENA
To: EPIC SCIENCES, INC.
Reel/Frame 049809/0372 →
Security Interest
Mar 31, 2021
From: EPIC SCIENCES, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 055785/0184 →
Assignment of Assignor's Interest
Dec 7, 2022
From: LAM, ERNEST; BLANKFARD, MARTIN; DHARAJIYA, NILESH; WENSTRUP, RICHARD
To: EPIC SCIENCES, INC.
Reel/Frame 062015/0752 →
Security Interest
Aug 22, 2024
From: EPIC SCIENCES, INC.
To: LABORATORY CORPORATION OF AMERICA HOLDINGS
Reel/Frame 068748/0873 →